775 related articles for article (PubMed ID: 36174227)
1. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Parrasia S; Szabò I; Zoratti M; Biasutto L
Mol Pharm; 2022 Nov; 19(11):3700-3729. PubMed ID: 36174227
[TBL] [Abstract][Full Text] [Related]
2. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
3. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
4. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
Zhang W
Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
[TBL] [Abstract][Full Text] [Related]
6. New technologies for drug delivery across the blood brain barrier.
Kabanov AV; Batrakova EV
Curr Pharm Des; 2004; 10(12):1355-63. PubMed ID: 15134486
[TBL] [Abstract][Full Text] [Related]
7. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
8. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
9. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.
Jafari B; Pourseif MM; Barar J; Rafi MA; Omidi Y
Expert Opin Drug Deliv; 2019 Jun; 16(6):583-605. PubMed ID: 31107110
[TBL] [Abstract][Full Text] [Related]
10. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.
Ruiz-López E; Schuhmacher AJ
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439797
[TBL] [Abstract][Full Text] [Related]
11. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
[TBL] [Abstract][Full Text] [Related]
12. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to brain via the blood-brain barrier.
Scherrmann JM
Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
[TBL] [Abstract][Full Text] [Related]
14. Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model.
Frøslev P; Franzyk H; Ozgür B; Brodin B; Kristensen M
Eur J Pharm Sci; 2022 Jan; 168():106054. PubMed ID: 34728364
[TBL] [Abstract][Full Text] [Related]
15. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
16. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial approaches for the identification of brain drug delivery targets.
Stutz CC; Zhang X; Shusta EV
Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
19. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
20. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
